- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0137426

Neopax India Private Limited
About Neopax India Private Limited
Data last updated:
Neopax India Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC357475. Its GSTIN is 27AAHCN5077A1ZJ (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suresh Kumar Rai and Arjun Prasad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 3 Plot No 43 Sector 42 Nerul, Navi Mumbai, Maharashtra, India – 400706.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.56 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹16,601 (net margin 0.8%) and EBITDA of ₹29,781 (EBITDA margin 1.4%).
As per MCA filings, the company has open charges of ₹4 Lakh on record.
Neopax India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0137426).
Company details
Recognitions & Rankings of Neopax India
Contact details
Neopax India Private Limited's registered office is in Navi Mumbai, Maharashtra.
- Registered AddressShop No 3 Plot No 43 Sector 42 Nerul, Navi Mumbai, Maharashtra, India – 400706
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neopax India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neopax India Private Limited, buy the company report.
Financials of Neopax India Private Limited
FY 2025 filings availableNeopax India Private Limited reported revenue of ₹20.56 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year. EBITDA fell 20% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29,781 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16,601 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neopax India Private Limited, buy the company report.
Board of directors of Neopax India Private Limited
Neopax India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Rai | Director | 20 Mar 2021 | 5 Years 7 Months | Current |
| Arjun Prasad | Director | 20 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Neopax India Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Denikem Specialties Private Limited | ₹20.59 Lakh (FY 2025) | 389.0% | Delhi, India | |||
| Zintol Herbal Private Limited | ₹20.59 Lakh (FY 2023) | Kolkata, West Bengal, India | ||||
| Kars Pharma Private Limited | ₹20.57 Lakh (FY 2024) | -61.0% | Cuttack, Odisha, India | |||
| Zingcare Biotech Private Limited | ₹20.57 Lakh (FY 2024) | -2.0% | Howrah, West Bengal, India | |||
| Neopax India Private Limitedthis company | ₹20.56 Lakh (FY 2025) | ₹16,601 | 0.8% | -3.0% | Navi Mumbai, Maharashtra, India | |
| Spanking Essential Products Private Limited | ₹20.53 Lakh (FY 2015) | -27.0% | Kolkata, West Bengal, India | |||
| Kritik Bio Fules Private Limited | ₹20.5 Lakh (FY 2022) | Hyderabad, Telangana, India | ||||
| Viraat Biosciences Private Limited | ₹20.47 Lakh (FY 2025) | -55.0% | Ankleshwar, Gujarat, India | |||
| Vishvakarma Chem & Pharma Private Limited | ₹20.46 Lakh (FY 2024) | -20.0% | Rajkot, Gujarat, India | |||
| Sharen Healthcare Private Limited | ₹20.46 Lakh (FY 2025) | 20.0% | Patna, Bihar, India |
To see the full peer comparison of Neopax India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2022 | 100614309 | Canara Bank | ₹4 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Neopax India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neopax India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neopax India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCN5077A1ZJ | Maharashtra | Active | 15 Apr 2021 |
To see the full GST registrations and return filing status of Neopax India Private Limited, buy the company report.
Recent activity
Neopax India Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Arjun Prasad was appointed as Director on 20 Mar 2021.
Frequently asked questions
Neopax India is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 March 2021 (5+ years old) and is registered under CIN U24290MH2021PTC357475.
Neopax India has 2 current directors:
- Suresh Kumar Rai - Director
- Arjun Prasad - Director
The latest financial statements of Neopax India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Neopax India is 27AAHCN5077A1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Neopax India is U24290MH2021PTC357475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neopax India was incorporated on 20 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Neopax India by revenue are Denikem Specialties Private Limited, Zintol Herbal Private Limited, Kars Pharma Private Limited, Zingcare Biotech Private Limited, Spanking Essential Products Private Limited and 4 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arjun Prasad was appointed as Director on 20 Mar 2021. Suresh Kumar Rai was appointed as Director on 20 Mar 2021.
Yes, Neopax India is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0137426).
The registered office of Neopax India is at Shop No 3 Plot No 43 Sector 42 Nerul, Navi Mumbai, Maharashtra, India – 400706.
Neopax India operates in the chemicals industry, in the manufacturing segment.

